Astellas seeks US FDA approval for tacrolimus ER capsules
Astellas Pharma US, Inc., a subsidiary of Tokyo-based Astellas Pharma Inc. has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the prophylaxis of organ ...
Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release ...Sacramento Bee
Astellas seeks FDA approval for tacrolimus tabletsPharmaceutical Business Review

all 15 news articles »